Navigation Links
Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech, 2013 Edition
Date:4/25/2013

ght into the terms included in a preclinical stage agreement, together with real world clause examples
- Understand the key deal terms companies have agreed in previous deals
- Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech includes

- Trends in preclinical stage dealmaking in the biopharma industry since 2007
- Analysis of preclinical stage deal structure
- Access to headline, upfront, milestone and royalty data
- Case studies of real-life preclinical stage deals
- Access to over 2,200 preclinical stage deals
- The leading preclinical stage deals by value since 2007
- Most active preclinical stage dealmakers since 2007
- The leading preclinical stage partnering resources

In Preclinical Stage Partnering Terms and Agreements in Pharm and Biotech, the available contracts are listed by:

- Company A-Z
- Headline value
- Stage of development at signing
- Deal type
- Specific therapy target

Key Topics Covered:

Chapter 1 - Introduction

Chapter 2 - Why do companies partner preclinical stage compounds?

Chapter 3 - Preclinical stage deal strategies and structure

Chapter 4 - Preclinical stage partnering payment strategies

Chapter 5 - Trends in preclinical stage deal making

Chapter 6 - Average payment terms for preclinical stage partnering

Chapter 7 - Leading preclinical stage deals

Chapter 8 - Big pharma and big biotech preclinical stage partnering deals

Chapter 9 - Preclinical stage partnering contracts directory

Chapter 10 - Preclinical stage dealmaking directory

For more information visit

SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology
2. AtheroNova Inc. Preclinical Study Demonstrates 95% Reduction in Arterial Plaque Formation
3. MultiCell Technologies Announces Positive Preclinical Results for MCT-465 and MCT-485 in Primary Liver Cancer In Vitro Models
4. Karyopharm Therapeutics announces the Publication of Two Preclinical Studies on the Activity of Selective Inhibitors of Nuclear Export (SINE) in Acute Myeloblastic Leukemia (AML)
5. Preclinical data shows 100 percent prevention and treatment of influenza with engineered human antibody
6. Karyopharm Therapeutics Announces Oral Presentation at the American College of Rheumatology (ACR) on the use of Selective Inhibitors of Nuclear Export (SINE) CRM1 Antagonists in preclinical models of Systemic Lupus Erythematosus (SLE)
7. Inovio Pharmaceuticals Cytomegalovirus (CMV) Synthetic Vaccine Constructs Generate Strong and Broad T-Cell Responses in Preclinical Study
8. Stemline Therapeutics, Inc. Announces Presentations of SL-401 Updated Clinical Trial Results in Acute Myeloid Leukemia (AML) and Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) and SL-101 Preclinical Efficacy Data Against Hodgkins Lymphoma at
9. RPCI-Led Study: FAK Inhibitor Proves Effective Against Brain Tumors in Preclinical Studies
10. PROLOR Biotech To Present New Preclinical Data On Its Long-Acting Clotting Factor VIIa At Leading European Scientific Conference
11. Translating Preclinical Pharmacology to Clinical Activity with Myriad RBM’s Inflammation MAP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... This report is a professional and ... an overview analysis, the report introduces quartz tubing ... industry overview, policy analysis, and news analysis, etc. ... witnessed rapid development with key manufacturers increasing their ... mentions quartz tubing upstream raw materials and equipment, ...
(Date:12/17/2014)... Dec. 17, 2014  United Therapeutics Corporation (NASDAQ: ... as well as changes to Martine Rothblatt , ... United Therapeutics announced the promotion of ... Executive Officer and David Zaccardelli , Pharm.D. to ... with these promotions, Dr. Rothblatt,s title will change from ...
(Date:12/15/2014)... Israel , Dec. 15, 2014  BrainStorm ... leading developer of adult stem cell technologies for neurodegenerative ... Ltd. was awarded a grant of approximately $1.1 million ... Chief Scientist (OCS).  This is the eighth year that ... the Office of the Chief Scientist, which is part ...
(Date:12/13/2014)... CanDiag, Inc., a University of North Carolina ... name to OncoTab, Inc. , “The new name ... today,” said CEO and Chief Science Officer, Dr. Pinku ... cancer diagnostics to include imaging and therapies, and our ... Founded in 2011 by Dr. Mukherjee, an Irwin Belk ...
Breaking Biology Technology:2020 Quartz Tubing Market: Global Development & Forecasts Analysis Now at DeepResearchReports.com 2United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 2United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 3United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 4BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 2BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 3CanDiag Inc. Expands Product Scope Under a New Name: OncoTab, Inc. 2
... /Xinhua-PRNewswire-FirstCall/ -- Shengtai,Pharmaceutical, Inc. (OTC Bulletin Board: ... manufacturer and distributor in China of high-,quality, ... industry and,glucose and starch products for food, ... of Ms. Melody Shi as its Chief ...
... May 1 DermAvance Pharmaceuticals, a,privately held ... skin health and cosmetic dermatology, today announced ... Technology Partners of,Southeastern Pennsylvania (BFTP/SEP). These funds ... will be used to complete the acquisition ...
... Cell Therapy Company,s Move Driven by Commitment of Governor and ... Collaboration with Leading Stem Cell Researcher, EWING, N.J., ... its East Coast operations in Ewing, N.J., The move, ... through the New Jersey Economic Development Authority,puts StemCyte,s executives in ...
Cached Biology Technology:Shengtai Pharmaceutical, Inc. Appoints New CFO 2Shengtai Pharmaceutical, Inc. Appoints New CFO 3DermAvance Pharmaceuticals Announces Investment by Ben Franklin Technology Partners of Southeastern Pennsylvania 2StemCyte Locates East Coast Operations in New Jersey 2
(Date:12/15/2014)... Research and Markets ( http://www.researchandmarkets.com/research/87pph8/global_facial ... "Global Facial Recognition Market 2015-2019" report to ... Facial recognition is a technology ... system measures the overall facial feature of a ... the distance between eyes. Facial recognition is used ...
(Date:12/11/2014)...  That blood pressure plays a role in human health ... medical term for high blood pressure – was first described ... cuff that,s used in measuring blood pressure was invented in ... about hypertension, its triggers and its effects. In fact, recent ... the best ways to treat it. For example, ...
(Date:12/10/2014)... Dec. 9, 2014  Valencell, a leader in performance ... a staggering demand from its licensees for highly accurate, ... is not solely coming from fitness and health sectors, ... "A wearable is only as useful as the ... the ultimate driver in long-term mass consumer adoption of ...
Breaking Biology News(10 mins):Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wearable Technology Products Demand Highly Accurate Biometric Technology 2
... ARBOR, Mich. Head and neck cancer patients who smoked, ... were diagnosed had worse survival outcomes than those with better ... of Michigan Comprehensive Cancer Center. "While there has been ... linked to cancer survival, the health habits a person has ...
... University College London Business PLC (UCLB) and Ocera Therapeutics ... of an exclusive worldwide licensing agreement for UCL-L1V and ... the treatment of acute hepatic encephalopathy (AHE). ... blood levels of ammonia, a highly toxic chemical that ...
... honored as the 2009 recipient of the Signature Genomic Laboratories ... 2009 Annual Clinical Genetics Meeting in Tampa, Florida. Dr. ... York General Hospital in Toronto, Canada. Dr. Chun received ... A new award in 2008, the Signature Genomics Travel Award ...
Cached Biology News:Health choices predict cancer survival, U-M study finds 2Ocera Therapeutics licenses novel treatment for acute hepatic encephalopathy from UCLB 2Ocera Therapeutics licenses novel treatment for acute hepatic encephalopathy from UCLB 3
... The ProteoExtract™ Protein Precipitation Kit is ... of proteins from aqueous samples. Proteomics ... the presence of non-protein impurities such ... the protein sample that interfere with ...
... luminometer provides the sensitivity and versatility you ... digital photon counting with selected photomultipliers ensure ... demands. Equipped with up to 2 reagent ... reporter gene assays as well as other ...
... high-speed analytical techniques, the AutoTrace SPE is a powerful, high-throughput workstation dedicated specifically ... loading and elution steps for large volumes aqueous solution extractions (up to 2000ml's). ... ... ...
... clear polystyrene with frosted labeling surfaces, ... cell counting. 100% integrity tested. Linkage: ... product number, created to easily match ... availability yet, please order under the ...
Biology Products: